No Prescription

No Prescription
HomeAlpha IndexCategories

Allergy

Anti Bacterial

Anti Convulsants

Anti Depressants

Anti Fungal

Anti Narcoleptic

Anti Viral

Antibiotics

Arthritis

Asthma

Birth Control

Blood Pressure

Cancer

Cardiovascular

Cholesterol

Diabetes

Diuretics

Eye Drops

Gastrointestinal

Hair Care

Herbal & Diet Supplements

Men's Health

Migraines

Muscle Relaxers

Nausea & Vomiting

Other

Pain Medicine

Pet Herbal Remedies

Prescription Drugs 1

Prescription Drugs 2

Prescription Drugs 3

Prescription Drugs 4

Prescription Drugs 5

Prescription Drugs 6

Prescription Drugs 7

Prescription Drugs 8

Prescription Drugs 9

Prescription Drugs 10

Prescription Drugs 11

Prescription Drugs 12

Prescription Drugs 13

Prescription Drugs 14

Prescription Drugs 15

Prescription Drugs 16

Prescription Drugs 17

Respiratory

Skin Care

Stop Smoking

Thyroid

Weight Loss

Women's Health

No Prescription

Alphabetical Index

Categories

6 MP Purinethol

No Prescription » Prescription Drugs 1 » 6 MP Purinethol

This medication is used with other drugs to treat a certain type of cancer (acute lymphocytic leukemia). Mercaptopurine belongs to a class of drugs known as purine antagonists. It works by slowing or stopping the growth of cancer cells.OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.This drug may also be used to treat Crohn's disease ulcerative colitis and lymphoblastic lymphoma.How to use Mercaptopurine OralTake this medication by mouth with or without food with a full glass of water (8 ounces or 240 milliliters) usually once daily or as directed by your doctor. Drink plenty of fluids while taking this medication unless otherwise directed by your doctor. Doing so may help decrease the risk of side effects (e.g. kidney stones).The dosage is based on your body weight medical condition and response to treatment. Do not increase your dose or take this medication more often than prescribed. Your condition will not improve any faster and the risk of serious side effects may be increased.Since this drug may be absorbed through the skin and lungs women who are pregnant or who may become pregnant should not handle this medication or breathe the dust from the tablets. Properly discard any unused medication. Ask your pharmacist for details.Mercaptopurine Oral is used to treat the following:Type of Leukemia - Acute Lymphocytic Leukemia Type of Leukemia - Acute Myeloid Leukemia Acute Promyelocytic Leukemia Acute Myelomonocytic LeukemiaMercaptopurine Oral may also be used to treat:Non-Hodgkin's Lymphoma Increased Red Blood Cells Inflammatory Bowel Disease Psoriasis associated with Arthritis.

Buy 6 MP Purinethol and other Prescription Drugs 1 products online at Medstore.

719
Buy Online at Medstore - Click Here!

About 6 MP Purinethol:

Product Type: Prescription Drugs 1

6-MP ( Purinethol Generic Mercaptopurine )

6-MP (Purinethol Generic Mercaptopurine)

Purinethol Generic Mercaptopurine

50mg Tabs 30 (3 x 10) Purinethol Generic Mercaptopurine 6-MP

View more Prescription Drugs 1

Previous Product  Next Product

No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.